Diaceutics PLC
LSE:DXRX
Diaceutics PLC
LSE:DXRX
Price:
127.5 GBX
Market Closed
Updated:
May 23, 2024
Diaceutics PLC
Operating Income
|
Diaceutics PLC
Operating Income Peer Comparison
Comparables:
ONT
O
ORPH
ERGO
C4XD
HVO
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Diaceutics PLC
LSE:DXRX
|
Operating Income
£575k
|
CAGR 3-Years
-35%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
N/A
|
|
|
Oxford Nanopore Technologies PLC
LSE:ONT
|
Operating Income
-£168.6m
|
CAGR 3-Years
-32%
|
CAGR 5-Years
-22%
|
CAGR 10-Years
N/A
|
|
O
|
Open Orphan PLC
LSE:ORPH
|
Operating Income
£6.1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Ergomed PLC
LSE:ERGO
|
Operating Income
£20.7m
|
CAGR 3-Years
25%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
C4X Discovery Holdings PLC
LSE:C4XD
|
Operating Income
£9.4m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
hVIVO PLC
LSE:HVO
|
Operating Income
£10.3m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Diaceutics PLC's Operating Income?
Operating Income
575k
GBP
575k
GBP
Based on the financial report for Dec 31, 2022, Diaceutics PLC's Operating Income amounts to 575k GBP.
What is Diaceutics PLC's Operating Income growth rate?
Operating Income CAGR 5Y
-9%
-9%
Over the last year, the Operating Income growth was 5%. The average annual Operating Income growth rates for Diaceutics PLC have been -35% over the past three years , -9% over the past five years .
You don't have any saved screeners yet
